preliminary
-
Biologics
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
– Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints – – Patient reported…
Read More » -
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31,…
Read More » -
Extremities
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
Stephen Deitsch resigns from his position as Chief Financial Officer to pursue another opportunity; Kristina Wright appointed interim Chief Financial…
Read More » -
Spine
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
— Preliminary data includes 26 and 52-week follow-up end points as part of ongoing Phase 2 trial — — Company…
Read More » -
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
AUDUBON, Pa., Jan. 10, 2024 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced…
Read More » -
Financial
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023
SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31,…
Read More » -
Financial
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
Net sales of $200.3 million, an increase of 64% on a reported basis and an increase of 8% on a…
Read More » -
Financial
OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023
WARSAW, Ind., Jan. 08, 2024 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively…
Read More » -
Financial
ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance
Full-year 2023 total revenue grew approximately 37% to over $480 million Expected full-year 2024 total revenue of $595 million CARLSBAD,…
Read More » -
Financial
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023
ENGLEWOOD, Colo., January 8, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively…
Read More » -
Financial
ATEC Announces Preliminary Third Quarter 2023 Revenue Results and Raises Full-Year Revenue Guidance
Total revenue of $117.7 to $118.5 million Total revenue growth of 31% to 32% Full-year 2023 total revenue now expected…
Read More » -
Financial
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30,…
Read More » -
Financial
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023
SANUWAVE is pleased to announce preliminary revenues of $4.5 million to $4.7 million for Q2 ended June 30, 2023 Results…
Read More » -
Financial
SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update
SALT LAKE CITY, Jan. 19, 2023 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original…
Read More » -
Financial
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
January 10, 2023 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively…
Read More »